Milica Medved to Protein Kinase Inhibitors
This is a "connection" page, showing publications Milica Medved has written about Protein Kinase Inhibitors.
Connection Strength
0.011
-
Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):4048-54.
Score: 0.011
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.